Pfizer/BioNTech have announced that logistical issues pertaining to the temperature storage of the COVID-19 vaccine will delay the second shipment of the jab to Malta and eight other countries.
Spanish authorities reported receiving a message from Pizer’s manufacturing plant in Belgium indicating a one-day delivery delay due to “a problem in the loading and shipping process related to temperature control.”
“Due to a minor logistical issue, we have rescheduled a limited number of our deliveries. The logistical matter has been resolved and those deliveries are now being dispatched,” Pfizer said in a statement to Euronews.
Malta received its first batch of 10,000 doses on Saturday with the roll out beginning the next day. It was meant to receive the second consignment yesterday. However, it now seems that the batch will be arriving today.
The first person to receive the vaccine was nurse Rachel Grech, followed by a number of frontliners, including virologist Chris Barbara who claimed he “didn’t feel the needle.”
The Pfizer/BioNTech vaccine was the first to be approved by the European Medicines Agency (EMA) and the first to be rolled out in the EU. Malta could also distribute the Moderna and AstraZeneca vaccines when and if they are approved by the EMA.
‘We realise the importance of Gozo as part of our economy’ – FBO Regulator
Joseph Gerada on the Gozitan microclimate, the urgency of succession planning, and the importance of corporate governance
Malta sets up group to make share trades settle faster by 2027
The move aligns Malta with a broader EU-wide initiative to shorten settlement times
Is Malta emerging as a preferred hub for EMI licensing as Lithuania tightens oversight?
People are highlighting Malta’s positioning as an alternative jurisdiction to Lithuania when it comes to EMI licensing